# Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Adult Patients for Pain Control During Spinal Injections (SI)

> **NCT03787147** · PHASE2 · WITHDRAWN · sponsor: **Albert Einstein College of Medicine**

## Conditions studied

- Pain

## Interventions

- **DEVICE:** Google Cardboard
- **DEVICE:** Oculus
- **DRUG:** Lidocaine Hydrochloride
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT03787147
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-11-30
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Never started the study cause of the lack of funding
- **Last updated:** 2021-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03787147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03787147, "Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Adult Patients for Pain Control During Spinal Injections (SI)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03787147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*